Data refreshed on 22.07.2026.
Salicylic Acid in Acne Products: Concentrations and Label Facts from FDA Data
Salicylic acid is a beta-hydroxy acid that appears across a wide range of over-the-counter (OTC) skincare products in the United States. Official product labels filed with the FDA reveal a consistent pattern: most acne-focused formulations list salicylic acid at a 2% concentration, while products intended for wart removal carry significantly higher concentrations. This article examines what those labels actually disclose — the stated strengths, labeled purposes, indicated uses, and required warnings — based entirely on data retrieved from the openFDA drug label API.
This article is informational only and does not constitute medical advice. It summarizes what official OTC product labels state. Readers with persistent acne, skin irritation, or other skin concerns should consult a licensed dermatologist or qualified healthcare provider.
What Strengths Appear on the Market?
The openFDA data retrieved for this article includes eight product label records containing salicylic acid. The concentrations found fall into two clear categories. For acne-labeled products, 2% salicylic acid is the concentration appearing on every label in this dataset. For wart-removal products, labels disclose significantly higher concentrations: one product lists 12% and another lists 20%. One multi-ingredient product also lists salicylic acid at 2% alongside sulphur 5% and benzoyl peroxide 2.5%, all identified on-label as acne medications.
The table below summarizes the products found in the FDA label data, organized by brand name where available, active ingredient strength, and the labeled purpose as stated on the product.
| Brand Name | Salicylic Acid Strength | Other Active Ingredients (if listed) | Labeled Purpose |
|---|---|---|---|
| CeraVe Acne Control Cleanser | 2% | None listed | Acne treatment |
| Clear Acne Spot Treatment | 2.0% | None listed | Acne treatment |
| Quick Action | 2% | None listed | Acne medication |
| Replenix Gly-Sal 10-2 Cleanser | 2% (USP) | None listed | Acne medication |
| Unlabeled multi-ingredient product | 2% | Sulphur 5%, Benzoyl Peroxide 2.5% | Acne medication (all three actives) |
| Unlabeled single-ingredient product | 2% | None listed | Acne treatment |
| Unlabeled wart product | 12% | None listed | Wart remover |
| Unlabeled wart product (multi-ingredient) | 20% | Salix Alba Bark 2%, Bifidobacterium Longum 1%, Glycyrrhizinate Dipotassium 0.2% | Wart remover |
What Do Labels Say Products Are For?
OTC drug labels are required to state a labeled use or indication. For acne products in this dataset, the language is consistent across filings. Labels state uses such as clearing acne blemishes, helping prevent new acne blemishes from forming, and treating conditions including whiteheads and blackheads. One label states the product “penetrates pores to reduce the number of acne pimples, whiteheads and blackheads.” Another, for the CeraVe Acne Control Cleanser, states that the product “clears acne blemishes and allows skin to heal” and “helps prevent new acne blemishes from forming.”
For wart-removal products, the labeled use is distinct from acne treatment. Labels in this dataset state these products are “for removal of common and plantar warts,” and provide descriptions to help consumers identify applicable wart types — for example, that common warts are “easily recognized by the rough cauliflower-like appearance of the surface,” and that plantar warts are located only on the bottom of the foot.
What Warnings Do Labels Include?
OTC drug labels are required by regulation to carry standardized warnings. The following summarizes — in paraphrased form — the categories of warnings that appear across the label records in this dataset.
Warnings Common to Acne Products
- Labels across multiple products state the product is for external use only.
- Several labels warn that skin irritation and dryness are more likely if the product is used alongside another topical acne medication at the same time, and advise using only one topical acne product at a time if irritation occurs.
- One label specifically advises against use on individuals with sensitive skin or sensitivity to the active ingredient.
- Multiple labels include a keep-out-of-reach-of-children statement and instructions to seek medical help if swallowed.
- The Replenix Gly-Sal label warns against use of other topical medications immediately after application, noting it may increase dryness or irritation, and advises discontinuing use and seeing a doctor if that occurs.
Warnings Specific to Wart-Removal Products
- Labels warn against use by individuals with diabetes or poor blood circulation.
- Labels caution against applying to irritated, inflamed, or reddened skin.
- Labels specifically state the product should not be used on moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes.
- One wart-removal product label includes a keep-away-from-fire-and-flame warning.
Frequently Asked Questions
What concentration of salicylic acid do acne product labels in this dataset list?
Every acne-labeled product in this openFDA dataset lists salicylic acid at 2%. This includes cleansers, a spot treatment, and a tonic system. The labeled purpose for all of these is either “acne treatment” or “acne medication.”
Are higher concentrations of salicylic acid found in acne products?
Based on the data retrieved, higher concentrations — 12% and 20% — appear only on products labeled for wart removal, not for acne treatment. These are categorized under a different labeled purpose and carry different warnings than acne products in the same dataset.
Do any products in this dataset combine salicylic acid with other active ingredients?
Yes. One product label lists salicylic acid 2% together with sulphur 5% and benzoyl peroxide 2.5%, with all three identified on the label as acne medications. A wart-removal product lists salicylic acid 20% alongside Salix Alba Bark 2%, Bifidobacterium Longum 1%, and Glycyrrhizinate Dipotassium 0.2%.
What do labels say about using salicylic acid acne products alongside other topical medications?
Several labels in this dataset specifically address this. The warning language states that skin irritation and dryness are more likely to occur when the product is used at the same time as another topical acne medication, and advises consumers to use only one topical acne product at a time if irritation develops.
Data Source
All ingredient concentrations, labeled purposes, indications, and warning summaries in this article are drawn exclusively from the openFDA drug label API (api.fda.gov), which provides official U.S. OTC product label data in the public domain. Data was retrieved on 2026-07-22. Readers should be aware that label data in the openFDA system reflects manufacturer label filings and may not represent every product currently available on the market. For the most current label information on a specific product, consult the product packaging or the FDA’s official DailyMed database.